APOE ε2 is associated with reduced risk of early post-stroke cognitive impairment but not with long-term functional outcome.

Although the cognitive function of ε4 carriers seemed to be worse than that of ε4 noncarriers, the results did not reach statistical significance (Table 2 ).

also in 111,027 other papers